Course Detail

Nonmedical use of opioids is a growing problem within the U.S. Pharmacists possess unique knowledge, skills, and responsibilities, which enables them to play a critical role in opioid abuse prevention, education, and assistance. The Buprenorphine/Naloxone Nonmedical Use and Diversion: The Role of the Pharmacist (KE-CN#PAIN105) course explores trends in opioid abuse, legal restrictions on opioid medications, and tips on identifying prescription fraud and red flags for diversion. Pharmacists who complete this training will have the knowledge and resources to identify signs of abuse and prevent opioid abuse.
Participants are strongly encouraged to successfully complete the following course to accompany Buprenorphine/Naloxone Nonmedical Use and Diversion: The Role of the Pharmacist (KE-CN#PAIN105):

• Treating Opioid Use Disorder with Buprenorphine/Naloxone (KE-CN#PAIN104)

Learning Objectives

1. Describe the magnitude of the problem of nonmedical use of buprenorphine;
2. Describe potential roles of the pharmacist in managing buprenorphine/naloxone patients and preventing drug diversion; and
3. Identify red flags of drug diversion.

CE: 1.0 Contact Hour
Universal Activity Number (UAN): 0025-0000-13-132-H04-P, 0025-0000-13-132-H04-T
Expiration Date: 12/2/2016
Course Number: KE-CN#PAIN105
Instructors: Bethany DiPaula, PharmD, BCPP, Associate Professor, University of Maryland School of Pharmacy & Wendy Klein-Schwartz, PharmD, MPH, Assistant Professor, University of Maryland School of Pharmacy.
Fee: $25.00

This course is sponsored in part by an educational grant from Reckitt Benckiser Pharmaceuticals

Click here for additional course details.